WallStreetZen

NYSE: MRK
Merck & Co Inc Stock Forecast, Predictions & Price Target

Analyst price target for MRK

Based on 5 analysts offering 12 month price targets for Merck & Co Inc.
Min Forecast
$93.00+20.98%
Avg Forecast
$98.80+28.53%
Max Forecast
$105.00+36.59%

Should I buy or sell MRK stock?

Based on 6 analysts offering ratings for Merck & Co Inc.
Strong Buy
Strong Buy
3 analysts 50%
Buy
2 analysts 33.33%
Hold
1 analysts 16.67%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

MRK stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDate
JP Morgan
Bottom 2%
2
Strong BuyMaintains$100.00+30.09%2021-06-09
Truist Securities
Top 21%
80
Strong BuyMaintains$93.00+20.98%2021-06-07
Goldman Sachs
Top 25%
76
Strong BuyUpgrades$105.00+36.59%2020-08-03
SVB Leerink
Bottom 2%
2
BuyMaintains$101.00+31.39%2021-07-30
Anonymous
Bernstein
BuyReinstates$95.00+23.59%2020-11-10
Argus Research
Top 31%
70
HoldDowngradesN/AN/A2021-05-20

1 of 1

Forecast return on equity

Is MRK forecast to generate an efficient return?
Company
72.26%
Industry
73.39%
Market
59.49%
MRK's Return on Equity is forecast to be high in 3 years (72.26%); analysts are confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is MRK forecast to generate an efficient return on assets?
Company
21.43%
Industry
16.5%
Market
15.35%
MRK is forecast to generate higher Return on Assets (21.43%) than the US Drug Manufacturers - General industry average (16.5%)
Forecast

MRK earnings per share forecast

What is MRK's earnings per share in the next 3 years based on estimates from 6 analysts?
Avg 1 year Forecast
$5.56+99.88%
Avg 2 year Forecast
$6.29+126.2%
Avg 3 year Forecast
$6.89+147.96%
MRK's earnings are forecast to grow at an exceptional rate of 35.59% per year
Forecast

MRK revenue forecast

What is MRK's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$46.2B-3.68%
Avg 2 year Forecast
$50.0B+4.14%
Avg 3 year Forecast
$51.9B+8.02%
MRK's revenue is forecast to grow at a rate of 2.81% per year, which is not exceptional
Forecast

MRK earnings growth forecast

How is MRK forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
35.59%
Industry
29.46%
Market
18.23%
MRK's earnings are forecast to grow faster (35.59% per year) than the US Drug Manufacturers - General industry average (29.46%)
Forecast
MRK's earnings are forecast to grow faster (35.59% per year) than the US market average (18.23%)
Forecast
MRK's earnings are forecast to grow faster (35.59% per year) than the risk-free savings rate (1.2%)
Forecast

MRK revenue growth forecast

How is MRK forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
2.81%
Industry
5.1%
Market
13.54%
MRK's revenues are forecast to grow slower (2.81% per year) than the US Drug Manufacturers - General industry average (5.1%)
Forecast
MRK's revenues are forecast to grow slower (2.81% per year) than the US market average (13.54%)
Forecast

Merck & Stock Forecast FAQ

Is Merck & Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NYSE: MRK) stock is to Strong Buy MRK stock.

Out of 6 analysts, 3 (50%) are recommending MRK as a Strong Buy, 2 (33.33%) are recommending MRK as a Buy, 1 (16.67%) are recommending MRK as a Hold, 0 (0%) are recommending MRK as a Sell, and 0 (0%) are recommending MRK as a Strong Sell.

What is MRK's earnings growth forecast for 2021-2023?

(NYSE: MRK) Merck &'s forecast annual earnings growth rate of 35.59% is forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 29.46%, and and it is also forecast to beat the US market's average forecast earnings growth rate of 18.23%.

Merck &'s earnings in 2021 is $7,028,000,000.On average, 6 Wall Street analysts forecast MRK's earnings for 2021 to be $14,069,888,711, with the lowest MRK earnings forecast at $13,875,679,835, and the highest MRK earnings forecast at $14,331,450,340. On average, 6 Wall Street analysts forecast MRK's earnings for 2022 to be $15,922,342,610, with the lowest MRK earnings forecast at $15,369,594,269, and the highest MRK earnings forecast at $16,863,508,704.

In 2023, MRK is forecast to generate $17,454,237,921 in earnings, with the lowest earnings forecast at $16,686,264,619 and the highest earnings forecast at $18,306,781,972.

What is MRK's revenue growth forecast for 2021-2023?

(NYSE: MRK) Merck &'s forecast annual revenue growth rate of 2.81% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 5.1%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.54%.

Merck &'s revenue in 2021 is $48,018,000,000.On average, 3 Wall Street analysts forecast MRK's revenue for 2021 to be $117,107,334,718,596, with the lowest MRK revenue forecast at $116,375,934,467,804, and the highest MRK revenue forecast at $118,406,695,916,899. On average, 3 Wall Street analysts forecast MRK's revenue for 2022 to be $126,614,732,784,326, with the lowest MRK revenue forecast at $123,399,864,369,540, and the highest MRK revenue forecast at $131,108,513,494,069.

In 2023, MRK is forecast to generate $131,339,267,568,955 in revenue, with the lowest revenue forecast at $126,058,525,651,740 and the highest revenue forecast at $137,945,147,038,620.

What is MRK's forecast return on assets (ROA) for 2021-2024?

(NYSE: MRK) forecast ROA is 21.43%, which is higher than the forecast US Drug Manufacturers - General industry average of 16.5%.

What is MRK's Price Target?

According to 5 Wall Street analysts that have issued a 1 year MRK price target, the average MRK price target is $98.80, with the highest MRK stock price forecast at $105.00 and the lowest MRK stock price forecast at $93.00.

On average, Wall Street analysts predict that Merck &'s share price could stay at $98.80 by Jul 30, 2022. The average Merck & stock price prediction forecasts a potential downside of N/A from the current MRK share price of $76.87.

What is MRK's Earnings Per Share (EPS) forecast for 2021-2023?

(NYSE: MRK) Merck &'s current Earnings Per Share (EPS) is $2.78. On average, analysts forecast that MRK's EPS will be $5.56 for 2021, with the lowest EPS forecast at $5.48, and the highest EPS forecast at $5.66. On average, analysts forecast that MRK's EPS will be $6.29 for 2022, with the lowest EPS forecast at $6.07, and the highest EPS forecast at $6.66. In 2023, MRK's EPS is forecast to hit $6.89 (min: $6.59, max: $7.23).

What is MRK's forecast return on equity (ROE) for 2021-2024?

(NYSE: MRK) forecast ROE is 72.26%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.